First Trust Direct Indexing L.P. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
First Trust Direct Indexing L.P. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$312,000
+11.4%
9,209
-4.8%
0.05%
+17.9%
Q2 2022$280,000
-2.8%
9,673
+8.6%
0.04%
+11.4%
Q1 2022$288,000
+20.5%
8,903
+8.8%
0.04%
+12.9%
Q4 2021$239,000
+9.6%
8,1830.0%0.03%0.0%
Q3 2021$218,000
+27.5%
8,183
+20.7%
0.03%
-32.6%
Q4 2020$171,0006,7820.05%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders